MRI in Reconstructive Urology
MRI is the pre-eminent soft tissue imaging modality for pelvic reconstructive surgery. Its multiplanar capability, superior soft tissue contrast, functional protocol flexibility, and absence of ionizing radiation make it indispensable across a wide spectrum of clinical problems — from pelvic fracture urethral injury gap measurement to carcinoma detection within a urethral diverticulum. This page provides protocol-level, clinically actionable MRI guidance for reconstructive urologists, urogynecologists, and pelvic surgeons.
1. Overview: Why MRI Is Uniquely Valuable in Reconstruction
Unmatched Soft Tissue Resolution
Conventional fluoroscopic studies (RUG, VCUG, cystogram) delineate only the contrast-filled lumen. MRI visualizes the surrounding tissue — the fibrotic bridge in a urethral obliteration, the levator ani avulsion behind a prolapsed vault, the horseshoe neck of a urethral diverticulum, or the inflammatory halo of a VVF tract. This tissue-level information is what determines surgical approach, graft sizing, and dissection planes.
No Ionizing Radiation
Pelvic reconstructive patients are frequently young women who will undergo serial imaging. Eliminating cumulative radiation exposure is clinically and ethically significant — especially for pediatric cases (ureteral reimplantation, posterior urethral valves) and for patients requiring multiple pre- and post-operative studies.
Multiplanar Acquisition
Unlike CT (retrospective reconstruction from axial source data), MRI acquires true 3-plane images. Coronal imaging of the urethral diverticulum shows circumferential extent; sagittal dynamic imaging shows compartment descent in real time; oblique imaging aligns precisely with the urethral axis for stricture length measurement.
Functional Protocols
MRI is not purely anatomical. Dynamic defecation MRI captures real-time compartment motion. Dynamic contrast-enhanced (DCE) sequences characterize bladder wall enhancement kinetics for VI-RADS staging. DWI sequences detect cellular-dense tumors and fibrotic tissue based on water diffusion restriction. These functional dimensions are unavailable with any other pelvic imaging modality.
:::info Key Point MRI complements — rather than replaces — fluoroscopic urethrography and urodynamics. The goal is integrating structural, functional, and tissue-level information to plan the correct operation. :::
2. Pelvic Fracture Urethral Injury (PFUI)
Background
Posterior urethral disruption complicates 5–10% of pelvic fractures. The essential pre-operative question is not whether injury is present (that is established by combined RUG/VCUG), but the precise anatomy of the obliteration: gap length, bladder neck integrity, stump angulation, degree of prostatic displacement, and the presence or absence of a fibrotic bridge. MRI answers these questions with a precision that fluoroscopy cannot match.
Full MRI Protocol for PFUI
| Parameter | Specification |
|---|---|
| Magnet strength | 1.5T minimum; 3T preferred for resolution |
| Coil | Phased-array pelvic coil; endorectal coil contraindicated (deforms anatomy) |
| Bladder status | Moderately full (150–200 mL) — provides bladder neck landmark |
| Suprapubic catheter | Leave clamped; fills posterior urethra retrograde |
| Timing | Optimally 3–6 months post-injury (scar maturation) |
Core Sequences
| Sequence | Plane | Slice Thickness | TR/TE | Clinical Target |
|---|---|---|---|---|
| T2 FSE (fast spin echo) | Sagittal | 3 mm, no gap | 3500/90 | Gap length, bladder neck position, pubic arch |
| T2 FSE | Axial | 3 mm, no gap | 3500/90 | Stump angulation, urethral remnant diameter, pelvic hematoma |
| T2 FSE | Coronal | 3 mm, no gap | 3500/90 | Lateral displacement, symphysis diastasis |
| T1 post-contrast (gadolinium) | Axial + sagittal | 3 mm | 500/10 | Fibrotic bridge enhancement, active inflammation |
| DWI (b = 0, 400, 800 s/mm²) | Axial | 4 mm | EPI | Fibrosis vs. healthy tissue; carcinoma exclusion |
| STIR | Coronal | 4 mm | 4000/60 | Bone marrow edema, pubic symphysis injury |
What to Measure on MRI
1. Gap Length Measure along the urethral axis on sagittal T2 from the distal aspect of the prostatic stump to the proximal edge of the bulbar urethral stump. This is the single most important surgical planning parameter. Measure in two planes and report the larger value.
2. Stump Position The prostatic apex may be displaced superiorly and posteriorly by hematoma or fibrosis. Report the vertical height of the prostatic apex above the perineal skin in the sagittal plane and the degree of posterior displacement relative to the pubic symphysis.
3. Stump Angulation Report the angle between the bladder neck axis and the urethral axis on sagittal T2. Significant angulation (>30°) predicts difficulty achieving a tension-free anastomosis by the standard perineal approach alone.
4. Fibrotic Bridge A low-signal-intensity T2 band connecting the two stumps may represent a fibrotic bridge rather than a true luminal gap. Post-contrast T1 and DWI help distinguish fibrosis (restricted diffusion, late enhancement) from residual patent lumen.
5. Pubic Symphysis Integrity STIR imaging identifies pubic symphysis diastasis, osteitis pubis, and bone marrow edema. Diastasis >10 mm is associated with a longer gap and more difficult reconstruction. Transcoccygeal or transperineal approach decisions are informed by symphyseal anatomy.
6. Bladder Neck Integrity Sagittal T2 at the bladder neck identifies sphincteric damage, posterior bladder neck descent, and bladder neck contracture. Bladder neck incompetence significantly worsens post-operative continence outcomes and should be documented pre-operatively.
:::warning Pitfall Gap length on MRI consistently exceeds RUG/VCUG measurement by 3–8 mm because MRI measures tissue gap while fluoroscopy measures the contrast column gap. Use MRI measurements for approach planning — not fluoroscopy measurements alone. :::
MRI vs. RUG: Comparative Table
| Feature | RUG + VCUG | MRI |
|---|---|---|
| Gap length accuracy | Moderate (underestimates) | High (true tissue gap) |
| Bladder neck evaluation | Limited (filling dependent) | Excellent |
| Prostatic stump position | Poor | Excellent |
| Fibrosis characterization | None | Excellent (T2/DWI) |
| Pubic symphysis | None | Excellent (STIR) |
| Pelvic floor muscles | None | Good |
| Radiation exposure | Yes | No |
| Dynamic filling | Yes | Limited |
| Availability | Universal | Center-dependent |
| Cost | Low | High |
Surgical Approach Decision Thresholds
| Gap Length (MRI) | Approach |
|---|---|
| <1 cm | Standard perineal bulbo-prostatic anastomosis |
| 1–3 cm | Extended perineal approach ± inferior pubectomy |
| >3 cm | Abdominoperineal approach; consider staged repair |
| >3 cm + BN incompetence | Abdominoperineal + simultaneous BN reconstruction or AUS staging |
:::tip Clinical Pearl The decision to perform inferior pubectomy is best made pre-operatively using MRI, not intraoperatively. Patients with gap >2 cm and high prostatic displacement benefit from pre-operative surgical planning that includes pubectomy. :::
3. Dynamic (Defecation) MRI for Pelvic Organ Prolapse
Indications
| Indication | Rationale |
|---|---|
| Discordant clinical exam and symptoms | Physical exam underestimates posterior compartment prolapse |
| Multicompartment prolapse | Define which compartments are dominant before surgery |
| Pre-surgical mapping (mesh or native tissue) | Identify enterocele, sigmoidocele, levator defects |
| Post-operative recurrence | Identify failed compartment and residual defects |
| Unexplained obstructed defecation | Rectocele vs. anismus vs. intussusception |
| Failed pelvic floor PT | Quantify defect severity before escalating treatment |
Protocol
Equipment and Setup
| Parameter | Specification |
|---|---|
| Magnet strength | 1.5T or 3T; open MRI acceptable for patient comfort |
| Coil | Phased-array pelvic coil |
| Patient prep | Cleansing enema 2 hours pre-scan; empty bladder immediately pre-scan |
| Rectal contrast | 200–250 mL ultrasound gel or gadolinium-saline suspension instilled rectally via rectal tube immediately before imaging |
| Vaginal contrast | Thin gauge instillation of ultrasound gel (optional but improves anterior rectocele delineation) |
| Patient positioning | Supine with knees slightly flexed over a bolster |
Imaging Phases
| Phase | Instruction | Sequences |
|---|---|---|
| Rest | Quiet breathing | T2 FSE sagittal (3 mm), T2 axial |
| Kegel/squeeze | Maximum pelvic floor contraction | T2 sagittal |
| Valsalva | Sustained strain (at least 5–10 sec) | T2 sagittal — 1 to 2 sec per acquisition |
| Defecation | Patient expels rectal gel onto absorbent pad | Fast T2 sagittal — 1 sec per frame, 20–30 frames |
| Post-void | Immediate post-defecation | T2 sagittal |
:::info Protocol Note Dynamic acquisitions during defecation require rapid single-shot T2 or HASTE sequences with frame rates of 1–2 images/sec. Gradient echo sequences can be used but have inferior tissue contrast. Ensure the image FOV captures the entire pubococcygeal line and the perineal body. :::
Pubo-Coccygeal Line (PCL) Reference
The PCL is drawn from the inferior aspect of the pubic symphysis to the last coccygeal joint on the sagittal T2 image. All organ descent is measured perpendicular to or as vertical drop below this line. This is the internationally accepted reference for dynamic pelvic MRI.
Normal positions (relative to PCL):
- Bladder base: at or above the PCL
- Cervix/vaginal vault: within 1 cm below the PCL
- Anorectal junction: within 3 cm below the PCL
Compartment Descent Grading Table
| Compartment | Structure | Mild | Moderate | Severe |
|---|---|---|---|---|
| Anterior | Bladder base (cystocele) | 1–3 cm below PCL | 3–6 cm below PCL | >6 cm below PCL |
| Middle | Cervix or vaginal vault | 1–3 cm below PCL | 3–6 cm below PCL | >6 cm below PCL |
| Posterior | Anorectal junction (rectocele) | 1–3 cm below PCL | 3–6 cm below PCL | >6 cm below PCL |
| Posterior | Rectocele depth | <2 cm (normal) | 2–4 cm | >4 cm |
| Posterior | Peritoneocele/enterocele | Bowel loops to PCL | Bowel loops >3 cm below PCL | Bowel contents to perineum |
Dietz Levator Ani Grading (Avulsion Scale)
Levator ani avulsion from the inferior pubic ramus is best visualized on axial T2 through the mid-levator plate.
| Grade | Description | Clinical Significance |
|---|---|---|
| 0 | Normal insertion — symmetric | No structural defect |
| 1 | Increased signal at insertion without morphologic change | Partial or healing avulsion |
| 2 | Morphologic change with partial detachment | Partial avulsion — moderate POP risk |
| 3 | Complete detachment from inferior pubic ramus | Full avulsion — highest POP/recurrence risk |
:::warning Surgical Implication Grade 3 bilateral levator avulsion is associated with significantly higher rates of anterior compartment prolapse recurrence after colporrhaphy (native tissue repair). Surgeons planning posterior compartment repair should identify levator grade pre-operatively to counsel patients regarding mesh augmentation vs. native tissue repair recurrence rates. :::
Clinical Utility Summary
Dynamic MRI prolapse imaging changes the surgical plan in 30–40% of cases compared to office examination alone, primarily by identifying occult posterior compartment pathology (enterocele, sigmoidocele) and levator avulsion not detected clinically. It is the only modality that simultaneously images all three compartments under physiologic strain.
4. Urethral Diverticulum
Why MRI Is the Gold Standard
Urethral diverticulum (UD) is a cystic outpouching of the periurethral glands communicating with the urethral lumen. It is frequently missed or incompletely characterized by VCUG, urethroscopy, or ultrasound. MRI provides:
- Precise neck location (anterior/posterior, proximal/mid/distal urethra)
- Circumferential extent (horseshoe vs. unilateral)
- Internal complexity (fluid, debris, calculus, solid nodule)
- Sphincter proximity (critical for surgical planning)
- Fistula identification
Key Sequence and Findings
Protocol:
| Sequence | Plane | Purpose |
|---|---|---|
| T2 FSE | Axial (3 mm, no gap) | Horseshoe morphology, neck location, sphincter relationship |
| T2 FSE | Sagittal | Length, posterior wall involvement |
| T2 FSE | Coronal | Lateral extent, vaginal fistula |
| T1 post-contrast | Axial + sagittal | Solid enhancement = carcinoma in UD |
| DWI (b800) | Axial | Restricted diffusion in malignancy |
Horseshoe Sign The pathognomonic finding of UD is the horseshoe-shaped hyperintense (T2) fluid-filled sac wrapping around the urethra on axial imaging. The sac neck (ostium) is typically posterior and at the level of the mid urethra. The relationship of the neck to the external urethral sphincter (EUS) must be explicitly described.
Internal Complexity and Carcinoma Risk
| Internal Content | T2 Signal | T1 Signal | Post-contrast | Clinical Action |
|---|---|---|---|---|
| Simple fluid | Bright | Dark | No enhancement | Standard diverticulectomy |
| Proteinaceous debris | Intermediate T2 | Bright T1 | No/rim enhancement | Drain + diverticulectomy |
| Calculus | Signal void | Signal void | No enhancement | Pre-operative lithotripsy vs. en-bloc excision |
| Solid nodule | Intermediate/low T2 | Variable | Avid enhancement | Biopsy — carcinoma in UD until proven otherwise |
:::warning Carcinoma Alert Adenocarcinoma arising within a urethral diverticulum is rare but well described. Any solid enhancing component on MRI mandates biopsy before surgical planning. The most common histology is adenocarcinoma (clear cell or mucinous), followed by transitional cell carcinoma. Do not proceed to diverticulectomy without excluding malignancy. :::
Surgical Planning Checklist from MRI
| Parameter | What to Report | Surgical Relevance |
|---|---|---|
| Neck location (clock position) | 3, 6, 9, 12 o'clock | Determines vaginal incision approach |
| Neck position on urethral axis | Proximal / mid / distal | Proximal neck = higher continence risk |
| Sphincter proximity | Distance from EUS to neck (mm) | <5 mm = high incontinence risk, consider staged SUI repair |
| Circumferential extent | Unilateral vs. horseshoe vs. circumferential | Circumferential = complex dissection, higher fistula risk |
| Fistula | Tract to vaginal wall or skin | Pre-operative counseling |
| Carcinoma | Solid enhancing component | Oncologic referral |
5. Vesicovaginal Fistula (VVF)
Role of MRI
Cystoscopy and EUA remain the primary tools for VVF diagnosis. MRI is indicated when:
- Fistula is not visualized endoscopically but symptoms are present
- Radiation-related fistula is suspected (tissue quality assessment)
- Ureteral proximity needs evaluation
- Planning transvaginal vs. transabdominal repair
- Multiple fistulae or complex anatomy is suspected
Sequences for VVF
| Sequence | Plane | Finding |
|---|---|---|
| T2 FSE | Sagittal | Fistula tract (high signal), bladder wall thickness, vaginal anatomy |
| T2 FSE | Axial | Lateral position, proximity to ureters, vaginal cuff involvement |
| T2 FSE | Coronal | Ureteral proximity, bladder dome integrity |
| T1 post-contrast | Sagittal + axial | Tract enhancement, inflammatory margins, radiation changes |
| DWI | Axial | Radiation-induced fibrosis (restricted diffusion in fibrotic walls) |
Fistula Tract Characteristics
Simple VVF: A linear T2 hyperintense tract connecting the posterior bladder wall to the anterior vaginal wall, typically at the level of the trigone or supratrigonal position. Tract length 5–15 mm. Bladder wall is otherwise normal thickness and signal.
Radiation-Related VVF: Diffuse T2 hypointensity and thickening of the bladder wall, rectum, and vaginal walls (fibrotic replacement). The fistula tract is often larger, more irregular, and surrounded by a hypovascular fibrous margin on post-contrast imaging. This pattern identifies poor tissue quality, predicting higher closure failure rates with transvaginal repair.
Surgical Approach Determination
| MRI Finding | Preferred Approach |
|---|---|
| Simple VVF, tract <10 mm, posterior wall, no radiation | Transvaginal with Martius flap |
| Trigonal VVF, ureteral proximity <5 mm | Transabdominal (O'Connor) with ureteral stenting |
| Supratrigonal / dome fistula | Transabdominal |
| Post-radiation VVF, fibrotic walls | Transabdominal ± omentoplasty; vaginal route high failure |
| Multiple fistulae / complex | Abdominal approach with full urinary diversion staging |
:::tip Ureteral Safety On T2 coronal imaging, identify both ureteral orifices relative to the fistula margin. Fistulae within 10 mm of a ureteral orifice mandate pre-operative ureteral stent placement regardless of surgical approach. Report ureteral proximity in the MRI interpretation. :::
6. MRI Urethrogram
Indications
MRI urethrography (MRU — not to be confused with MR urography) refers to dedicated high-resolution T2 sequences of the male or female urethra for stricture assessment. Indications include:
- Male anterior urethral stricture when SUG is unavailable or suboptimal
- Spongiofibrosis characterization (depth, circumferential extent)
- Posterior urethral anatomy (membranous/prostatic urethra) after radical prostatectomy or radiation
- Female urethral stricture (rare, but fibrosis extent determines surgical approach)
- Failed urethroplasty evaluation
Spongiofibrosis Visualization
The corpus spongiosum is T2 hyperintense (vascular, water-rich tissue). Fibrosis replaces this signal with T2 hypointensity. The key advantage of MRI over fluoroscopic RUG:
| Feature | RUG | SUG | MRI |
|---|---|---|---|
| Luminal narrowing | Yes | Yes | Yes |
| Spongiofibrosis depth | No | Yes (partial) | Yes |
| Periurethral fibrosis | No | Partial | Yes |
| Bulbospongiosus muscle | No | No | Yes |
| Posterior urethra | VCUG needed | Partial | Yes |
| Urethral carcinoma exclusion | No | No | Yes (DWI/DCE) |
Fibrosis Grading on MRI (Buckley-McAninch adaptation):
| Grade | MRI Appearance | Surgical Implication |
|---|---|---|
| Mild | Partial T2 signal loss, mucosa intact | Shorter resection margin needed |
| Moderate | Full-thickness spongiosum signal loss, <50% circumference | EPA feasible |
| Severe | Circumferential signal loss, periurethral extension | Staged augmented anastomosis or flap urethroplasty |
Posterior Urethra
Membranous and prostatic urethral anatomy is well seen on sagittal T2. After radical prostatectomy, the anastomotic scar is visible as a T2 hypointense band. Dynamic contrast may show stricture enhancement vs. recurrent tumor — critical distinction before planning anastomotic revision vs. oncologic re-staging.
Female Urethral Stricture
Female urethral stricture is underdiagnosed. MRI shows circumferential periurethral fibrosis on axial T2 as a low-signal ring around the urethral lumen. Proximal strictures near the bladder neck suggest iatrogenic cause; distal strictures suggest trauma or lichen sclerosus. Pre-operative MRI guides the decision between urethral dilation, meatotomy, and formal urethroplasty.
7. Peyronie's Disease
Role of MRI
Peyronie's disease is a fibromatosis of the tunica albuginea presenting as penile curvature, indentation (hourglass deformity), and sometimes pain. MRI is not the first-line investigation — clinical examination and erect photographs remain primary — but MRI is the most accurate tool for:
- Plaque mapping (location, dimensions, calcification)
- Hourglass deformity characterization (waist circumference, residual lumen)
- Vascular assessment (dynamic contrast for associated erectile dysfunction)
- Surgical planning (plication site, graft dimensions for grafting procedures)
:::info Erect Photography Protocol For documentation of curvature, a standardized erect photograph protocol should accompany MRI referral: three images (straight, left lateral, right lateral) taken by the patient using pharmacological erection (trimix 0.2 mL intraurethral or physician-supervised ICI), uploaded to patient portal. MRI is performed in the flaccid state. :::
Peyronie's MRI Protocol
| Sequence | Plane | Purpose |
|---|---|---|
| T2 FSE | Axial (2–3 mm, no gap) | Plaque signal, tunica integrity, urethral displacement |
| T2 FSE | Sagittal | Plaque length along shaft axis |
| T1 FS (fat-saturated) | Axial | Distinguishes calcification (signal void) from fibrosis |
| T2* GRE | Axial | Calcification blooming artifact — most sensitive for calcification |
| DCE (dynamic contrast) | Axial | Cavernosal artery inflow — erectile function assessment |
| Post-contrast T1 FS | Axial + sagittal | Plaque enhancement = active phase (inflammatory) |
Plaque Characteristics on MRI
Active Phase (acute): T2 intermediate signal plaque with post-contrast enhancement. Surrounding edema. Patient typically has pain. Medical therapy (colchicine, pentoxifylline, vitamin E) may still be effective. Surgery is not indicated in active phase.
Stable Phase (chronic): T2 hypointense plaque, no enhancement. Calcification appears as signal void on T2/T1 and blooms on T2* GRE. Surgery is appropriate when plaque is stable for >6 months.
Surgical Relevance
| MRI Finding | Surgical Implication |
|---|---|
| Dorsal plaque only | Plication vs. dorsal graft |
| Ventral plaque | Ventral plication (higher ED risk); ventral graft for curvature >45° |
| Hourglass deformity (waist <60% shaft diameter) | Graft plaque excision; sizing from MRI measurement |
| Calcified plaque | Limited graft take; penile prosthesis as primary option in ED patients |
| Lateral curvature | Bilateral plication vs. opposite-side graft |
| Plaque length >4 cm | Grafting preferred over plication |
8. VI-RADS for Bladder Cancer
Overview
The Vesical Imaging Reporting and Data System (VI-RADS) is a standardized 5-point scoring system for multiparametric MRI (mpMRI) of the bladder, developed to assess the probability of muscle-invasive bladder cancer (MIBC). Published by Panebianco et al. in 2018, VI-RADS is increasingly adopted before transurethral resection of bladder tumor (TURBT) to reduce the rate of understaging.
mpMRI Sequences Used in VI-RADS
| Sequence | Role |
|---|---|
| T2 FSE (axial, 3 mm) | Structural bladder wall layers, tumor morphology |
| DWI (b0/b800/ADC map) | Tumor cellularity, muscle layer disruption |
| DCE (dynamic contrast) | Early arterial enhancement of muscle-invasive tumors |
VI-RADS Scoring System
| Score | Description | Probability of MIBC |
|---|---|---|
| 1 | No mass OR small papillary lesion, intact low-signal muscle on T2 and DWI | Very low (<5%) |
| 2 | Superficial mass, intact muscle layer on T2 and DWI, no early DCE in muscle | Low (<10%) |
| 3 | Equivocal — disruption of inner muscle layer uncertain on at least one sequence | Intermediate (30–40%) |
| 4 | Disruption of inner muscle layer on T2 and/or DWI | High (65–75%) |
| 5 | Clear muscle invasion, extravesical extension on T2 and DWI | Very high (>90%) |
:::tip Threshold for Decision-Making A VI-RADS score of 3 or higher should prompt re-evaluation for primary muscle-invasive disease before TURBT. VI-RADS 4–5 strongly favors radical cystectomy planning over repeat TURBT alone. :::
Relevance to Reconstructive Urologists
Reconstructive urologists encounter VI-RADS in several specific clinical contexts:
| Clinical Scenario | VI-RADS Role |
|---|---|
| Pre-augmentation cystoplasty | Exclude urothelial malignancy in radiation-damaged or contracted bladders before augmentation |
| Post-radiation bladder evaluation | Distinguish radiation-induced fibrosis (VI-RADS 1–2) from occult muscle-invasive recurrence (VI-RADS 4–5) |
| Neurogenic bladder with hematuria | Screen for malignant transformation before major reconstruction |
| Bladder outlet reconstruction | Identify trigonal or bladder neck lesions before reconstructive procedures |
| Orthotopic neobladder surveillance | Detect recurrence at anastomotic site or in neobladder mucosa |
9. Upper Tract / MR Urography (MRU)
Indications for MRU Over CT or MAG3
| Clinical Situation | Preferred Modality | Why |
|---|---|---|
| Pediatric UPJ obstruction | MRU | No radiation; anatomical + functional in single session |
| Contrast allergy or renal insufficiency | MRU | Gadolinium at reduced dose (0.05 mmol/kg) with caution |
| Complex duplicated system anatomy | MRU | Superior spatial delineation of crossing vessels, ectopic insertions |
| Pregnancy (non-first trimester) | MRU | No radiation; avoids iodinated contrast |
| Ureteral anatomy before reconstruction | MRU | 3D ureteral course in relation to pelvic vasculature |
| Inconclusive MAG3 (equivocal T½) | MRU | Dynamic contrast corroborates functional data |
:::warning MRU Limitations vs. MAG3 MRU provides inferior quantitative split renal function data compared to Tc-99m MAG3 nuclear scintigraphy. MAG3 remains the gold standard for split function. MRU gadolinium-enhanced functional data is semiquantitative and scanner/protocol dependent. Use MRU primarily for anatomy and use MAG3 for quantitative function. :::
MRU Protocol
Static MRU (anatomical):
| Sequence | Purpose |
|---|---|
| Heavily T2-weighted 3D RARE/HASTE | Urothelial filling defects, ureteral course, hydronephrosis |
| T2 FSE axial/coronal (thin slice) | Periureteral anatomy, vessel crossing |
| STIR coronal | Perirenal inflammation, retroperitoneal fibrosis |
Dynamic Gadolinium-Enhanced MRU (functional):
| Phase | Sequence | Information |
|---|---|---|
| Pre-contrast | T1 3D GRE | Baseline signal |
| Corticomedullary (30 sec) | T1 3D GRE | Cortical perfusion |
| Nephrographic (90 sec) | T1 3D GRE | Parenchymal transit |
| Excretory (5–10 min) | T1 3D GRE | Collecting system filling, ureteral drainage |
| Post-furosemide (20–40 mg IV at 15 min) | T1 3D GRE | Diuresis challenge — obstruction vs. dilated non-obstructed |
Furosemide Administration in MRU: Administer furosemide 15 minutes after gadolinium injection (F+15 protocol). This is equivalent to the F-15 protocol in MAG3 scintigraphy and provokes ureteral washout. Absent or sluggish washout post-furosemide on MRU indicates functional obstruction.
Pediatric Advantage
MRU is particularly valuable in children because:
- No ionizing radiation (cumulative dose concern over multiple VCUG/CT studies)
- Single-session anatomy and function (one anesthetic event)
- Superior soft tissue contrast for duplicated systems, ectopic ureters, and ureteroceles
- 3D reconstruction for pre-operative planning (robotic pyeloplasty templating)
10. MRI Sequence Quick Reference Table
| Indication | T2 FSE | STIR | T1 (plain) | DWI | DCE | T2* GRE |
|---|---|---|---|---|---|---|
| PFUI gap measurement | Primary sequence (sagittal) | Pubic symphysis edema | — | Fibrosis vs. lumen | Fibrotic bridge enhancement | — |
| Dynamic prolapse MRI | Primary (sagittal cine) | — | — | — | — | — |
| Urethral diverticulum | Primary (axial horseshoe) | — | — | Malignancy screen | Solid nodule characterization | — |
| VVF | Tract visualization | — | — | Radiation fibrosis | Tract/inflammatory margins | — |
| MRI urethrogram | Spongiofibrosis (axial) | — | — | Fibrosis characterization | Stricture enhancement | — |
| Peyronie's disease | Plaque signal | — | Calcification FS | — | Active phase | Calcification (blooming) |
| VI-RADS (bladder Ca) | Muscle layer integrity | — | — | Primary staging sequence | Kinetic enhancement | — |
| MR urography | Collecting system (static) | Retroperitoneal | Pre-contrast baseline | — | Dynamic functional | — |
11. Practical Protocol Tips
Magnet Strength: 1.5T vs. 3T
| Parameter | 1.5T | 3T |
|---|---|---|
| Signal-to-noise ratio | Baseline | ~2× higher |
| Spatial resolution achievable | Good | Superior |
| Susceptibility artifacts (DWI, bowel) | Lower | Higher |
| T2* artifact (bowel gas, implants) | Lower | Higher |
| Cost/availability | More accessible | Less accessible |
| Preferred use | Dynamic prolapse MRI, routine VVF | PFUI gap measurement, VI-RADS, UD carcinoma |
For PFUI gap measurement and VI-RADS staging, 3T is preferred when available. For dynamic prolapse MRI, 1.5T is sufficient and produces fewer motion artifacts. Open-bore 3T systems are preferred for claustrophobic patients requiring dynamic protocols.
Coil Selection
| Coil Type | Best Used For | Avoid For |
|---|---|---|
| Phased-array pelvic coil (surface) | All pelvic indications as default | — |
| Endorectal coil | Prostate MRI only | PFUI (deforms anatomy), UD, prolapse |
| Cardiac coil (small surface) | Penile MRI (Peyronie's) | Pelvic applications |
| Body coil (built-in) | Large FOV survey | High-resolution applications |
Patient Preparation
| Condition | Preparation | Rationale |
|---|---|---|
| All pelvic MRI | Antispasmodic (e.g., hyoscine butylbromide 20 mg IV or glucagon 1 mg IV 5 min pre-scan) | Reduces bowel motion artifact |
| Bladder tumour (VI-RADS) | Moderate bladder filling (150–200 mL) | Optimizes wall thickness and lesion conspicuity |
| PFUI | Suprapubic tube clamped; moderate bladder distension | Bladder neck visualization |
| Dynamic prolapse | Cleansing enema + rectal gel immediately pre-scan | Posterior compartment opacification |
| Peyronie's | No special preparation; cardiac coil positioned at bedside | Penile immobilization during acquisition |
| VVF | Moderate bladder filling; tampon in vagina (optional) | Vaginal wall delineation |
:::tip Antispasmodic Use Hyoscine butylbromide (Buscopan, 20 mg IV) is effective and inexpensive. It is contraindicated in glaucoma and tachyarrhythmia. In these patients, glucagon 1 mg IV is an acceptable alternative. Antispasmodics are not needed for PFUI or Peyronie's protocols. :::
Bladder Filling Protocol
For PFUI and VI-RADS, optimal bladder filling is 150–200 mL. Overfilled bladder thins the wall and reduces VI-RADS sequence sensitivity. Underfilled bladder collapses the bladder neck and obscures PFUI landmarks. Have the patient void 1 hour before the scan and drink 200 mL of water. Aim to scan within 30–60 minutes.
Rectal Contrast for Prolapse MRI
Commercial ultrasound gel (not barium, not water-soluble contrast) provides excellent T2 bright rectal opacification. Instill 200–250 mL rectally with the patient on the scanner table 5 minutes before imaging. Gadolinium-saline mix (1:50) can be used if T1 sequences are planned but is unnecessary for routine T2 dynamic protocols.
12. References
-
Koraitim MM. Pelvic fracture urethral injuries: evaluation of various methods of management. J Urol. 1996;156(4):1288–1291. PMID: 8808856
-
Mundy AR, Andrich DE. Pelvic fracture-related injuries of the bladder neck and posterior urethra: a urological perspective. BJU Int. 2010;105(9):1302–1308. doi:10.1111/j.1464-410X.2009.09062.x
-
Dixon CM, Hricak H, McAninch JW. Magnetic resonance imaging of traumatic posterior urethral defects and pelvic crush injuries. J Urol. 1992;148(4):1162–1165. PMID: 1404644
-
Narumi Y, Hricak H, Armenakas NA, Dixon CM, McAninch JW. MR imaging of traumatic posterior urethral injury. Radiology. 1993;188(2):439–443. doi:10.1148/radiology.188.2.8327691
-
Panebianco V, Narumi Y, Altun E, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018;74(3):294–306. doi:10.1016/j.eururo.2018.04.029
-
Dietz HP, Bhatt R, Bhatt S. Levator trauma is associated with pelvic organ prolapse. BJOG. 2007;114(1):42–46. doi:10.1111/j.1471-0528.2006.01187.x
-
Coolen AWM, van Oudheusden AMJ, Mol BWJ, et al. Dynamic MRI vs. clinical assessment of pelvic organ prolapse: a systematic review. Ultrasound Obstet Gynecol. 2012;40(3):268–278. doi:10.1002/uog.11118
-
Shobeiri SA, Rostaminia G, White D, Quiroz LH. The determinants of minimal levator hiatus and their relationship to the puborectalis muscle and the levator plate. BJOG. 2013;120(2):205–211. doi:10.1111/1471-0528.12038
-
Blander DS, Rovner ES, Schnall MD, et al. Endoluminal magnetic resonance imaging in the evaluation of urethral diverticula in women. Urology. 2001;57(4):660–665. doi:10.1016/s0090-4295(00)00955-9
-
Chung DE, Purohit RS, Girshman J, Blaivas JG. Urethral diverticula in women: discrepancy between MRI and intraoperative findings. J Urol. 2010;183(6):2265–2269. doi:10.1016/j.juro.2010.02.012
-
Srinivasan AK, Gruber D, Hurwitz RS. Carcinoma arising in a urethral diverticulum: MRI features and review of the literature. J Urol. 2007;177(6):2079–2082. doi:10.1016/j.juro.2007.01.133
-
El-Mekresh MM, El-Baz MA, Abol-Enein H, Ghoneim MA. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol. 1998;82(2):206–212. PMID: 9722758
-
Kadioglu A, Sanli O, Akman T, Canguven O, Aydin M, Akbulut F, Cil U. Factors affecting the outcomes of Peyronie's disease surgery. J Sex Med. 2011;8(1):242–251. doi:10.1111/j.1743-6109.2010.01919.x
-
Rouviére O, Cornelis F, Brunelle S, et al. Dynamic MRI of pelvic floor: Technique and indications. Diagn Interv Imaging. 2019;100(11):711–720. doi:10.1016/j.diii.2019.07.006
-
Nolte-Ernsting CC, Bücker A, Adam GB, et al. Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography. Radiology. 1998;209(1):147–157. doi:10.1148/radiology.209.1.9769824